<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/91554.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Small biotech company + simple molecules = High Profits!</title>
     <link>http://www.prweb.com/releases/2004/04/prweb120057.htm</link><description>   <![CDATA[ <P>Two products are ready for Herpes market, HERPEX-C and HERPEX-O, which are projected to generate $11 million in net profits for the first year of sales and a novel new gp41 inhibitor which could compete with a new anti-HIV/AIDS drug which according to experts should generate $400M-$800M in first year sales! (PRWeb Apr 21, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/04/prweb120057.htm">http://www.prweb.com/releases/2004/04/prweb120057.htm</a></P>]]>
                </description><pubDate>Wed, 21 Apr 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/04/prweb120057.htm</guid>
        </item>
</channel>
</rss>